Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Short-Term Debt repayments (2016 - 2026)

Usana Health Sciences has reported Short-Term Debt repayments over the past 9 years, most recently at $4.0 million for Q2 2026.

  • Quarterly Short-Term Debt repayments changed N/A to $4.0 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $30.6 million through Apr 2026, up 340100.0% year-over-year, with the annual reading at $26.6 million for FY2026, 1713.22% up from the prior year.
  • Short-Term Debt repayments was $4.0 million for Q2 2026 at Usana Health Sciences, up from $2.0 million in the prior quarter.
  • Over five years, Short-Term Debt repayments peaked at $24.6 million in Q2 2025 and troughed at -$60.0 million in Q1 2022.
  • The 4-year median for Short-Term Debt repayments is $500000.0 (2022), against an average of -$4.1 million.
  • The largest YoY upside for Short-Term Debt repayments was 33433.33% in 2026 against a maximum downside of 33433.33% in 2026.
  • A 4-year view of Short-Term Debt repayments shows it stood at $500000.0 in 2022, then crashed by 101.2% to -$6000.0 in 2024, then soared by 410100.0% to $24.6 million in 2025, then tumbled by 83.74% to $4.0 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Short-Term Debt repayments are $4.0 million (Q2 2026), $2.0 million (Q1 2026), and $24.6 million (Q2 2025).